Horizon announces TEPEZZA® (teprotumumab-trbw) Has Resumed Production.

Patients who have been affected by the TEPEZZA supply disruption can talk with their doctor about their plan for starting or resuming treatment and share their plan with their infusion center. Patients can contact their infusion center directly to schedule their infusions or call their Horizon Patient Access Liaison (PAL) if they have questions about the process of starting or resuming treatment. Additional information is available in this FAQ document.